Dhofar Food & Investment SAOG (MSM:DFIN)
Oman · Delayed Price · Currency is OMR 0.0720
0.00 (0.00%)
At close: Aug 4, 2025
Sage Therapeutics Income Statement
Financials in millions OMR. Fiscal year is January - December.
Millions OMR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
| 98.83 | 87.37 | 56.71 | 36.83 | 39.89 | 40.4 | Upgrade | |
Revenue Growth (YoY) | 27.72% | 54.05% | 53.97% | -7.65% | -1.26% | -1.58% | Upgrade |
Cost of Revenue | 85.74 | 76.13 | 49.99 | 32.66 | 35.29 | 33.77 | Upgrade |
Gross Profit | 13.09 | 11.23 | 6.72 | 4.17 | 4.6 | 6.62 | Upgrade |
Selling, General & Admin | 13.46 | 13.83 | 8.12 | 7.76 | 7.19 | 7.64 | Upgrade |
Other Operating Expenses | -0.86 | -0.86 | -1.56 | -1.61 | -0.13 | -1.72 | Upgrade |
Operating Expenses | 12.6 | 12.97 | 6.56 | 6.15 | 7.06 | 5.92 | Upgrade |
Operating Income | 0.49 | -1.74 | 0.16 | -1.98 | -2.46 | 0.71 | Upgrade |
Interest Expense | -2.72 | -2.6 | -1.99 | -1.66 | -1.35 | -1.31 | Upgrade |
Interest & Investment Income | - | 0.11 | 0.11 | 0.18 | 0.22 | 0.16 | Upgrade |
Earnings From Equity Investments | -0.01 | 0.01 | 0.18 | 1.01 | 0.11 | -0 | Upgrade |
EBT Excluding Unusual Items | -2.23 | -4.22 | -1.54 | -2.46 | -3.48 | -0.44 | Upgrade |
Gain (Loss) on Sale of Investments | - | - | 0.93 | - | - | - | Upgrade |
Gain (Loss) on Sale of Assets | -0.02 | -0.02 | 0 | 0.01 | 0.06 | - | Upgrade |
Asset Writedown | - | - | - | - | 0.09 | - | Upgrade |
Pretax Income | -2.2 | -4.2 | -0.48 | -2.44 | -3.32 | -0.44 | Upgrade |
Income Tax Expense | 0.17 | -0.02 | -0.07 | 0.41 | 0.01 | -0.01 | Upgrade |
Earnings From Continuing Operations | -2.38 | -4.18 | -0.41 | -2.85 | -3.33 | -0.43 | Upgrade |
Minority Interest in Earnings | 0.08 | 0.08 | 0.1 | 0.09 | 0.18 | - | Upgrade |
Net Income | -2.29 | -4.09 | -0.32 | -2.76 | -3.14 | -0.43 | Upgrade |
Net Income to Common | -2.29 | -4.09 | -0.32 | -2.76 | -3.14 | -0.43 | Upgrade |
Shares Outstanding (Basic) | 198 | 174 | 174 | 81 | 81 | - | Upgrade |
Shares Outstanding (Diluted) | 198 | 174 | 174 | 81 | 81 | - | Upgrade |
Shares Change (YoY) | -14.49% | - | 115.60% | - | - | - | Upgrade |
EPS (Basic) | -0.01 | -0.02 | -0.00 | -0.03 | -0.04 | - | Upgrade |
EPS (Diluted) | -0.01 | -0.02 | -0.00 | -0.03 | -0.04 | - | Upgrade |
Free Cash Flow | - | -10.07 | 4.45 | -1.7 | -1.21 | 2.73 | Upgrade |
Free Cash Flow Per Share | - | -0.06 | 0.03 | -0.02 | -0.01 | - | Upgrade |
Gross Margin | 13.24% | 12.86% | 11.85% | 11.32% | 11.53% | 16.40% | Upgrade |
Operating Margin | 0.50% | -1.99% | 0.28% | -5.38% | -6.17% | 1.75% | Upgrade |
Profit Margin | -2.32% | -4.69% | -0.56% | -7.48% | -7.88% | -1.05% | Upgrade |
Free Cash Flow Margin | - | -11.52% | 7.84% | -4.62% | -3.02% | 6.77% | Upgrade |
EBITDA | 4.4 | 2.2 | 1.35 | -0.51 | -0.71 | 2.58 | Upgrade |
EBITDA Margin | 4.45% | 2.51% | 2.38% | -1.37% | -1.77% | 6.39% | Upgrade |
D&A For EBITDA | 3.9 | 3.93 | 1.19 | 1.48 | 1.76 | 1.87 | Upgrade |
EBIT | 0.49 | -1.74 | 0.16 | -1.98 | -2.46 | 0.71 | Upgrade |
EBIT Margin | 0.50% | -1.99% | 0.28% | -5.38% | -6.17% | 1.75% | Upgrade |
Advertising Expenses | - | 1.69 | 0.16 | 0.08 | 0.19 | 0.17 | Upgrade |
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.